BVF »

Molecular Partners shares owned by BVF

Quarter-by-quarter ownership of Molecular Partners (MOLN) shares owned by BVF from 13F filings

Historical chart of BVF investment in Molecular Partners

Tip: Access up to 7 years of quarterly data

All positions including Molecular Partners held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Molecular Partners by BVF

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 443k 3.98
2023-09-30 $1.8M 443k 3.99
2023-06-30 $2.7M 443k 6.11
2023-03-31 $2.7M 443k 6.00
2022-12-31 $2.9M 443k 6.48
2022-09-30 $3.0M 443k 6.70
2022-06-30 $3.0M 443k 6.73
2022-03-31 $9.0M 443k 20.27
2021-12-31 $8.5M 443k 19.29
2021-09-30 $8.3M 419k 19.73

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Revolution Medicines (RVMD)
Axsome Therapeutics (AXSM)
Protagonist Therapeutics (PTGX)
Kymera Therapeutics (KYMR)
Mirum Pharmaceuticals (MIRM)
Olema Pharmaceuticals (OLMA)
Ionis Pharmaceuticals (IONS)
Kura Oncology (KURA)
4d Molecular Therapeutics In (FDMT)
Galapagos Nv Spon Adr (GLPG)
Merus N V (MRUS)
Repare Therapeutics Ord (RPTX)
Ac Immune Sa SHS (ACIU)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for BVF

Top funds holding Molecular Partners

BVF
Tang Capital Management
Rhumbline Advisers
Jpmorgan Chase & Co

View all funds holding Molecular Partners